The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

To help provide relief without the risk of abuse and overdoses, one pharmaceutical company is revealing its new pill designed ...

This approval is considered a major breakthrough in treating acute pain without the need for opioid medication as reliance on ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators.

Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The following is a summary of “A year in review: new treatments and expanded indications in dermatology in 2024,” published in the January 2025 issue of Dermatology by McGrath et al. In 2024, ...

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...